4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-061588
SVP & Chief Scientific Officer returned 4,782 shares (to the company)
- SVP & Chief Scientific Officer acquired 17,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Doberstein Stephen K · SVP & Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-15 | Grant or award : show line 1 in the form | +17,500 | 48,602 | D | ||
| 2017-11-16 | Returned to the company : show line 2 in the form | −4,782 | $44.23 | $211,508 | 43,820 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-11-15 | Grant or award : show line 3 in the form Stock Option | +43,750 | 43,750 | D |
Loading xslF345X03/doc4.xml…